{
    "other_tests": [
        {
            "procedure_name": "CSF examination",
            "date": "Not specified",
            "findings": "CSF examination was normal.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Blood studies",
            "date": "Not specified",
            "findings": "Mild microcytic anemia (131 g/L) with acanthocytes; mildly elevated transaminases; serum alpha-tocopherol (vitamin E) 50% of normal (7.2 μmol/L, normal 15–41 μmol/L); vitamin E: total cholesterol ratio 1.46 (normal 2.22–10); serum ceruloplasmin 20% of normal (34 mg/L, normal 200 mg/L); and serum copper 10% of normal (1.1 μmol/L, normal 11.0–26.0 μmol/L).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "MRI of the brain",
            "date": "Not specified",
            "findings": "Cerebellar atrophy, most evident in the vermis.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "EMG",
            "date": "Not specified",
            "findings": "Mild slowing of sensory nerve conduction velocities.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Evoked Potentials",
            "date": "Not specified",
            "findings": "Delayed visual evoked responses and markedly diminished or absent sensory evoked potentials.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Repeat serum alpha-tocopherol test",
            "date": "6 months after initiation of replacement therapy",
            "findings": "27.3 μmol/L (normal).",
            "changes_over_time": "Moderate improvement in cerebellar function and gait documented after 12 months of vitamin E and copper replacement therapy."
        }
    ]
}